KYORIN Pharmaceutical Co.,Ltd. <4569> moves little after announcing start of confirmatory trial for chronic cough treatment app
KYORIN Pharmaceutical Co.,Ltd. <4569> shares were little changed after announcing after the close today it started a confirmatory clinical trial for its chronic cough treatment app "KRP-DC125." The app is being co-developed with U.S.-based Hyfe, Inc. The trial will evaluate the efficacy and safety of adding the app to standard treatment for patients whose condition has not sufficiently responded to existing therapies. KYORIN also announced the launch of a new product.
Source: MINKABU PRESS
*Translated by generative AI. Click here for the original article.
Related Articles
-
Marumae opens with buy-only quotes after raising FY8/2026 earnings forecast and dividend on strong orders
Fri Jun 12, 2026 9:06 am JST Catalyst -
Asahi Group Holdings FY25 earnings to fall short of guidance
Thu Jun 11, 2026 4:58 pm JST Catalyst -
Tokyo stocks seen extending sharp gains on hopes for Iran ceasefire, semiconductor shares to lead rebound
Fri Jun 12, 2026 8:00 am JST Market -
Japan M&A hits limit-up on raised earnings and dividend forecasts for FY10/2026
Fri Jun 12, 2026 9:31 am JST Catalyst -
THine Electronics surges after proposal selected in Ministry of Internal Affairs' R&D public offering for radio resource expansion
Fri Jun 12, 2026 9:23 am JST Catalyst -
Singapore Nikkei 225 futures open at 66,550 yen (+2,060 yen) on the 12th
Fri Jun 12, 2026 8:38 am JST Market -
U.S. stocks surge on the 11th, Dow jumps 929 dollars to reclaim 50,000 level on hopes for end to Iran conflict
Fri Jun 12, 2026 8:12 am JST Market -
TSE investor trading data: foreign investors net sellers of cash equities for second straight week in first week of June
Thu Jun 11, 2026 6:41 pm JST Market -
Tokyo Market Outlook: Spotlight returns to chemical stocks as hidden gems in semiconductor supply chain
Thu Jun 11, 2026 5:30 pm JST Market -
J.S.B., First Half Ordinary Profit Increases by 10%, Postponed Dividend for This Fiscal Year
Fri Jun 12, 2026 7:30 pm JST Earnings